2024
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology.
Hodan R, Gupta S, Weiss J, Axell L, Burke C, Chen L, Chung D, Clayback K, Felder S, Foda Z, Giardiello F, Grady W, Gustafson S, Hagemann A, Hall M, Hampel H, Idos G, Joseph N, Kassem N, Katona B, Kelly K, Kieber-Emmons A, Kupfer S, Lang K, Llor X, Markowitz A, Prats M, Niell-Swiller M, Outlaw D, Pirzadeh-Miller S, Samadder N, Shibata D, Stanich P, Swanson B, Szymaniak B, Welborn J, Wiesner G, Yurgelun M, Dwyer M, Darlow S, Diwan Z. Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology. Journal Of The National Comprehensive Cancer Network 2024, 22: 695-711. PMID: 39689429, DOI: 10.6004/jnccn.2024.0061.Peer-Reviewed Original ResearchMeSH KeywordsColorectal NeoplasmsEndometrial NeoplasmsFemaleGenetic Predisposition to DiseaseGenetic TestingHumansMaleMedical OncologyNeoplastic Syndromes, HereditaryRisk AssessmentStomach NeoplasmsConceptsMultigene panel testingPathogenic/likely pathogenic variantsGenetic/Familial High-Risk AssessmentColon cancer screeningColon cancer riskHigh risk of cancerNCCN Clinical Practice GuidelinesClinical practice guidelinesRisk of cancerPanel testingHigh riskPathogenic variantsPeutz-Jeghers syndromeLynch syndromeCancer screeningDe-implementationCancer riskEndometrial cancerPTEN hamartoma tumor syndromeHigh-risk assessmentPractice guidelinesHamartoma tumor syndromePeutz-JeghersNCCN GuidelinesCHEK2
2016
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Daly M, Pilarski R, Axilbund J, Berry M, Buys S, Crawford B, Farmer M, Friedman S, Garber J, Khan S, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom P, Merajver S, Offit K, Pal T, Rana H, Reiser G, Robson M, Shannon K, Swisher E, Voian N, Weitzel J, Whelan A, Wick M, Wiesner G, Dwyer M, Kumar R, Darlow S. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. Journal Of The National Comprehensive Cancer Network 2016, 14: 153-62. PMID: 26850485, DOI: 10.6004/jnccn.2016.0018.Peer-Reviewed Original ResearchMeSH KeywordsBreast NeoplasmsFemaleGenetic CounselingGenetic Predisposition to DiseaseGenetic TestingHumansMutationNeoplastic Syndromes, HereditaryOvarian NeoplasmsPancreatic NeoplasmsRisk AssessmentRisk FactorsConceptsGenetic/Familial High-Risk AssessmentHigh-risk assessmentOvarian cancer risk reductionGenetic testing criteriaNCCN Guidelines InsightsCancer risk reductionRisk of breastHereditary cancer syndromesCommon genetic mutationsOvarian cancer histologiesNCCN guidelinesMultigene testingPancreatic cancerOvarian cancerCancer histologyCancer syndromesGenetic testingBreastPanel meetingGenetic mutationsPersonal historySyndromeRisk reductionCancerManagement recommendations